XWELL (XWEL) to Release Earnings on Tuesday

XWELL (NASDAQ:XWEL) is anticipated to release its Q4 2025 resultson Tuesday, April 21st. Analysts expect XWELL to post earnings of ($1.00) per share and revenue of $2.3710 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, April 1, 2026 at 7:00 AM ET.

XWELL (NASDAQ:XWEL) last posted its quarterly earnings results on Wednesday, April 1st. The company reported ($3.29) earnings per share (EPS) for the quarter. The company had revenue of $7.15 million during the quarter. XWELL had a negative net margin of 58.17% and a negative return on equity of 352.37%.

XWELL Price Performance

XWEL stock opened at $1.17 on Monday. The firm has a market capitalization of $9.28 million, a P/E ratio of -0.23 and a beta of 0.96. The business’s 50-day moving average is $1.08 and its two-hundred day moving average is $0.84. XWELL has a 1 year low of $0.26 and a 1 year high of $2.20.

Analyst Ratings Changes

A number of research analysts have recently commented on XWEL shares. Wall Street Zen upgraded XWELL to a “sell” rating in a report on Saturday, April 11th. Weiss Ratings reiterated a “sell (e+)” rating on shares of XWELL in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.